Gainers
- BiondVax Pharmaceuticals BVXV shares moved upwards by 54.72% to $2.29 during Wednesday's pre-market session. The company's market cap stands at $32.8 million.
- BioRestorative Therapies BRTX stock increased by 38.29% to $6.32. The company's market cap stands at $22.0 million.
- DBV Technologies DBVT stock increased by 17.26% to $1.63. The market value of their outstanding shares is at $179.2 million.
- Cocrystal Pharma COCP stock increased by 13.28% to $0.81. The market value of their outstanding shares is at $78.9 million.
- SenesTech SNES stock increased by 8.73% to $1.12. The company's market cap stands at $13.6 million.
- Galera Therapeutics GRTX shares moved upwards by 7.7% to $4.75. The market value of their outstanding shares is at $125.5 million.
Losers
- Allakos ALLK stock fell 86.47% to $11.42 during Wednesday's pre-market session. The market value of their outstanding shares is at $620.2 million.
- Statera BioPharma STAB shares declined by 8.49% to $2.05. The company's market cap stands at $65.7 million.
- Titan Pharmaceuticals TTNP shares declined by 6.88% to $1.22. The company's market cap stands at $12.0 million.
- PAVmed PAVM stock fell 5.85% to $2.9. The market value of their outstanding shares is at $254.9 million.
- iSpecimen ISPC shares fell 5.74% to $13.47. The market value of their outstanding shares is at $117.5 million.
- Quoin Pharmaceuticals QNRX stock decreased by 5.61% to $2.02. The market value of their outstanding shares is at $16.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BRTXBioRestorative Therapies Inc
$2.1819.8%
COCPCocrystal Pharma Inc
$1.68-5.88%
DBVTDBV Technologies SA
$4.171.71%
GRTXGalera Therapeutics Inc
$0.04309.69%
ISPCiSpecimen Inc
$1.62-6.90%
PAVMPAVmed Inc
$0.7400-3.39%
QNRXQuoin Pharmaceuticals Ltd
$0.31300.97%
SNESSenesTech Inc
$3.20-3.03%
STABStatera BioPharma Inc
$0.00010-%
TTNPTitan Pharmaceuticals Inc
$3.45-6.50%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in